Simon Fraser University announced on March 3, 2020 that researchers in its Brinkman Laboratory have collaborated with U.S. researchers to analyze a new drug that can kill a wide range of superbugs. (Simon Fraser University photo)

Human trials underway after B.C. researchers analyze effects of new ‘superbug-killing compound’

Brinkman Lab in Burnaby helped analyze effects of new drug after University of Cincinnati discovery

Researchers at Simon Fraser University’s Brinkman Lab in Burnaby participated in a landmark study that tests how a new drug can kill a range of superbugs – including some bacteria now resistant to all common antibiotics.

According to a March 3 release, researchers at the University of Cincinnati discovered two inexpensive chemicals work to kill disease-causing bacteria more effectively when combined.

The U.S. researchers combined the chemicals — ethylenediaminetetraacetic acid and acidified nitrite — to create the new drug known as AB569.

ALSO READ: B.C. widow sues health authority after ‘untreatable’ superbug killed husband

SFU researchers then used computers to analyze data from bacteria treated with the new drug. The results from the study indicated the drug can kill pathogens identified by the World Health Organization as urgently requiring new treatments, and posing the greatest threat to human health.

For example, the top three “priority pathogens” include Pseudomonas aeruginosa, a type of bacteria that can cause infections in the lungs, urinary tract, or blood that is known as the leading cause of morbidity in patients with cystic fibrosis.

Erin Gill, a PhD researcher at the University of British Columbia during the study and now at the Brinkman Lab, was involved in the analysis. She told Black Press Media by phone that it was inspiring to be part of “such a large, collaborative project.”

“It’s really important work to be able to contribute to the discovery of potentially novel drugs that can help to kill bacteria, because we’re running out of them,” Gill said.

The lab’s lead database developer Geoff Winsor agreed.

“We have a growing crisis with antibiotics becoming less and less effective, and treatments are failing,” Winsor said. “That’s why it’s important to test and develop new drugs and approaches to treat disease-causing bacteria that are highly resistant to existing antibiotics.”

The new drug is currently in the first phase of human trials that are being managed by Toronto-based biotechnology firm Arch Biopartners.

“I think they’re going to have some results from that soon,” Winsor said.

ALSO READ: SFU reviewing security measures after data breach exposes personal information

Correction: This story has been updated. The University of Cincinnati was responsible for testing the new AB569 drug, not the SFU Brinkman Lab.



karissa.gall@blackpress.ca

Like us on Facebook and follow us on Twitter

SFU

Get local stories you won't find anywhere else right to your inbox.
Sign up here

Just Posted

6.5-magnitude earthquake in Idaho shakes the Kootenays

An earthquake was reportedly felt just before 5 p.m. throughout parts of B.C. and Alberta

Castlegar and Trail Chevron offering free gas for front line workers

Health care, fire, police, paramedics included in offer

Grand Forks distillery shifts to make sanitizer

How a Grand Forks distillery is stepping up during the COVID-19 pandemic

Trail arts council hopeful for show-filled season come fall

Cancelled events include Sunday Cinema, Silver City Days, and family shows

Man launches West Kootenay shuttle service for those in need

Business owner Mike Sherwood said he’s been getting ten call requests a day from people

B.C. records five new COVID-19 deaths, ‘zero chance’ life will return to normal in April

Province continue to have a recovery rate of about 50 per cent

John Horgan extends B.C.’s state of emergency for COVID-19

Premier urges everyone to follow Dr. Bonnie Henry’s advice

B.C.’s first community COVID-19 death was dentist ‘dedicated’ to health: lawyer

Vincent was 64 when he died on March 22 after attending the Pacific Dental Conference

Two inmates at prison housing Robert Pickton test positive for COVID-19

Correctional Service of Canada did not release any details on the identities of the inmates

COVID-19 case confirmed at restaurant in Cache Creek: Interior Health

Customers who visited the site from March 25 to 27 are asked to self-isolate

BC SPCA launches matching campaign to help vulnerable animals after big donations

Two BC SPCA donors have offered up to $65,000 in matching donations

First COVID-19 outbreak in Interior Health identified at Okanagan agricultural business; 14 cases confirmed

75 workers are in isolation — 63 migrant workers and 12 local workers

Quarantined B.C. mom say pandemic has put special-needs families in ‘crisis mode’

Surrey’s Christine Williams shares family’s challenges, strengths

Anti-tax group calls for MPs, senators to donate scheduled pay raises to charity

Bill C-30, adopted 15 years ago, mandates the salary and allowance increases each calendar year

Most Read